Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Immunomedics Inc (NASDAQ:IMMU)

3.46
Delayed Data
As of May 05
 -0.28 / -7.49%
Today’s Change
1.50
Today|||52-Week Range
5.05
+12.70%
Year-to-Date

Today’s Trading

Previous close3.74
Today’s open3.73
Day’s range3.41 - 3.76
Volume1,468,703
Average volume (3 months)979,130
Market cap$354.3M
Dividend yield--
Data as of 3:59pm ET, 05/05/2016

Growth & Valuation

Earnings growth (last year)-21.43%
Earnings growth (this year)+18.63%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)-37.48%
P/E ratioNM
Price/Sales67.02
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ARAYAccuray Inc-0.07-1.34%
ENTLEntellus Medical Inc+1.68+12.11%
HTWRHeartWare Internatio...-0.05-0.17%
AXGNAxoGen Inc-0.09-1.57%
Data as of 3:59pm ET, 05/05/2016

Financials

Next reporting dateAugust 18, 2016
EPS forecast (this quarter)-$0.01
Annual revenue (last year)$5.7M
Annual profit (last year)-$48.0M
Net profit margin-849.13%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Scientific &
Patent Officer
David M. Goldenberg
President, Chief Executive Officer &
Director
Cynthia L. Sullivan
Corporate headquarters
Morris Plains, New Jersey

Forecasts

Partner Offers

Search for Jobs